Delivery Order SPE2DB20D3101-SPE2DB25FRWE4
- Not listed
- The Defense Logistics Agency awarded a $37,967.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in packages of 30 units. This delivery order, which is a child contract under a larger vehicle, requires completion by September 4, 2025, and was competitively awarded without set-aside provisions. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $14,221.61 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on September 22, 2025, with final delivery required by September 23, 2025. This non-competitive delivery order utilizes firm fixed-price pricing and represents a routine pharmaceutical supply transaction under the company's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $10,627.40 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed-price, competitively awarded contract with no set-aside designation leverages AmerisourceBergen's position as a major pharmaceutical distributor supporting federal medical procurement. The work will be performed at the company's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $31,905.60 on August 1, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $61,163.00 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price, non-set-aside contract represents a direct pharmaceutical supply delivery under the company's broader Indefinite Delivery Contract relationship with DLA. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $55,915.11 delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,096.32 delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-competitive delivery order with no set-aside designation. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate office and primary distribution hub for...
- The Defense Logistics Agency awarded a delivery order valued at $28,781.38 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a pharmaceutical supply requirement fulfilled from AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $74,049.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of September 15, 2025. This competitive award, issued on September 12, 2025, carries no set-aside designation and represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical procurement needs. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $24,643.14 to supply BIKTARVY 50-200-25 mg tablets (30-count units) with a firm fixed price structure and completion date of September 10, 2025. This non-set-aside, competitively awarded contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The place of performance is the company's corporate office in Conshohocken,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWE4Delivery Order
The Defense Logistics Agency awarded a $78,264 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of BIKTARVY (50-200-25 mg tablets) in quantities of 30-tablet units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures and scheduled for completion by September 23, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $78.3k | 9/22/25 |